Seretra
✅ Reduces airway inflammation
✅ Improves lung function
✅ Relieves asthma symptoms
✅ Prevents bronchoconstriction
✅ Enhances respiratory health
Seretra contains Seratrodast.
✓ Medisch beoordeeld door Morgan Ellis — Apotheekonderzoeker · 8 jaar ervaring · Laatst beoordeeld: mei 2026
⚡ Quick Answer — What is Seretra?
Seretra bevat seratrodast 80 mg, een selective thromboxane A2 (TXA2) receptor antagonist used as preventer therapy for asthma and allergic rhinitis. Seratrodast blocks the TXA2 receptor on bronchial smooth muscle, eosinophils, and platelets — preventing TXA2-mediated bronchoconstriction, eosinophil recruitment, and airway hyperresponsiveness. It was developed and is mainly used in Japan; less widely available outside Asia. Used as add-on preventer alongside ICS in patients with persistent asthma. Onset of preventer benefit takes 1–2 weken of daily dosing.
📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.
Waarom bestellen bij MedsBase
Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.
What Is Seretra?
Seretra contains seratrodast — a niche anti-asthma agent introduced in Japan in 1995. Seratrodast targets the thromboxane A2 (TXA2) receptor — a contrast to leukotriene receptor antagonists (montelukast) which target the cysteinyl leukotriene receptor. Both TXA2 and leukotrienes are inflammatory mediators released during the allergic cascade.
How Does Seratrodast Work?
- TXA2 receptor blockade on bronchial smooth muscle prevents TXA2-mediated bronchoconstriction
- Reduces eosinophil recruitment to airways
- Decreases airway hyperresponsiveness over 1–2 weeks of dosing
- Mild platelet inhibition — TXA2 is a potent platelet aggregator; this effect is rarely clinically significant
Toepassingen en Indicaties
- Persistent asthma — add-on preventer when ICS alone is inadequate
- Allergic rhinitis — adjunct
- Cough-variant asthma
- Aspirin-exacerbated respiratory disease (AERD) — niche use
Seretra Dosage
| Patient | Dosering | Frequentie |
|---|---|---|
| Adults | 80 mg | Once daily after dinner |
| Leverfunctiestoornis | Reduce dose 50% | Eénmaal daags |
Side Effects of Seretra
- Nausea, dyspepsia
- Hoofdpijn
- Mild dizziness
- Mild liver enzyme elevation
- Rarely: rash, fatigue
Serious — stop and seek help:
- Hepatitis (jaundice, dark urine, RUQ pain)
- Ernstige allergische reactie
- Severe persistent vomiting
Waarschuwingen en voorzorgsmaatregelen
- Liver function monitoring: baseline LFTs and periodic monitoring during long-term use.
- Continue ICS if previously prescribed; seratrodast is add-on, not replacement.
- Not a rescue medication. Use SABA (Asthalin, Levolin) for acute attacks.
- Zwangerschap en borstvoeding: limited data; avoid unless benefit clear.
- Bleeding disorders: mild TXA2 inhibition could theoretically prolong bleeding; rarely clinically significant.
Contra-indicaties
- Hypersensitivity to seratrodast
- Ernstige leverfunctiestoornis
- Active hepatitis
Geneesmiddelinteracties
- Aspirin and other antiplatelet agents — additive bleeding risk (rarely clinically significant)
- Warfarin — monitor INR
- Other hepatotoxic drugs — monitor LFTs
Opslag
- Store below 25°C in a cool, dry place away from direct sunlight.
- Keep in original packaging until use to protect from moisture and light.
- Do not use after the expiry date printed on the strip.
- Keep out of reach of children.
Gerelateerde alternatieven op MedsBase
- Asthalin Inhaler — salbutamol reliever
- Budecort Inhaler — budesonide ICS preventer
- Foracort Inhaler — budesonide + formoterol ICS-LABA
- Montair — montelukast LTRA tablet
- Tiova Inhaler — tiotropium LAMA for COPD
Veelgestelde vragen
How is seratrodast different from montelukast?
Both block specific allergic mediators. Montelukast (Montair) blocks the cysteinyl leukotriene CysLT1 receptor. Seratrodast blocks the thromboxane A2 receptor. Different mediators, different targets, similar add-on niche. Montelukast has more global use and a stronger evidence base; seratrodast is mainly used in Japan and parts of Asia.
Can I take Seretra alongside montelukast?
Combination is not standard. Discuss with your prescriber — there is no established additional benefit over ICS-LABA + LTRA.
How long until Seretra works?
1–2 weeks for noticeable improvement; 4–8 weeks for full preventer effect on exacerbation rate.
Is Seretra a rescue inhaler?
No — onset is far too slow. Use a SABA (Asthalin, Levolin) for acute attacks.
Why monitor liver function?
Mild liver enzyme elevation is a known side effect. Baseline LFTs and periodic monitoring are recommended.
Will Seretra replace my inhaler?
No — seratrodast is an oral add-on. Continue ICS or ICS-LABA inhaler therapy.
Is Seretra evidence-based?
Yes, but mainly through Japanese trials. Evidence base is smaller than for montelukast or ICS-LABA combinations. Reasonable as add-on in selected patients.
Can children take Seretra?
Limited paediatric data; specialist supervision required.
Is Seretra safe in pregnancy?
Limited data; avoid unless benefit clear.
Gerelateerde alternatieven
Andere producten in Chronische aandoeningen die klanten ook bekijken:
More options in Asthma/COPD Treatment
Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.
| Sterkte | 80 mg |
|---|---|
| Hoeveelheid | 30 Tabletten, 60 Tabletten, 90 Tabletten, 180 Tabletten |
Seretra
Vragen & antwoorden
Seretra
Gerelateerde producten
Beoordelingen
Er zijn nog geen beoordelingen